Suezanne Parker

Suezanne Parker has extensive work experience in the pharmaceutical industry. Suezanne began their career at Biogen Idec in 2001, initially serving as the Director of Pharmacotoxicology and later transitioning to become the Director of the Department of Preclinical Safety. Suezanne worked at Biogen Idec until 2014. Following their time at Biogen Idec, Parker joined Shire as a Senior Director, where they worked from 2014 to 2018. Currently, they are employed at Arcturus Therapeutics, starting as the Vice President of Translational Biology in 2018 and subsequently being promoted to Senior Vice President of Translational Biology in December 2020.

Suezanne Parker pursued their education from 1983 to 1987 at UC Santa Barbara, where they obtained a Ph.D. in Biochemistry and Molecular Biology.